MOTS vs. NMRD, VIVE, UTRS, DRTSW, ANZUW, IONM, ATAKW, BBLGW, BRSHW, and BRSH
Should you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include Nemaura Medical (NMRD), Viveve Medical (VIVE), Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and Bruush Oral Care (BRSH). These companies are all part of the "medical equipment" industry.
Motus GI vs.
Nemaura Medical (NASDAQ:NMRD) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.
Nemaura Medical has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500. Comparatively, Motus GI has a beta of 0.28, meaning that its stock price is 72% less volatile than the S&P 500.
4.4% of Nemaura Medical shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 40.4% of Nemaura Medical shares are owned by insiders. Comparatively, 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Motus GI has higher revenue and earnings than Nemaura Medical. Motus GI is trading at a lower price-to-earnings ratio than Nemaura Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.
Motus GI received 159 more outperform votes than Nemaura Medical when rated by MarketBeat users. Likewise, 65.73% of users gave Motus GI an outperform vote while only 57.14% of users gave Nemaura Medical an outperform vote.
Summary
Motus GI beats Nemaura Medical on 6 of the 9 factors compared between the two stocks.
Get Motus GI News Delivered to You Automatically
Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Motus GI Competitors List
Related Companies and Tools
This page (NASDAQ:MOTS) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy MOTS Stock Free MOTS Stock Alerts